|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.82% | -3.77% | -2.83% | +13.63% | +3.38% | -2.49% | +14.92% | -27.75% | +199.73% | 48.41B | |
| -1.29% | -1.22% | +1.06% | +39.62% | +160.29% | +404.92% | +545.45% | +584.68% | - | 45.01B | |
| -3.20% | +0.33% | +8.59% | +41.11% | +14.99% | +38.11% | +21.39% | -1.03% | +232.96% | 44.07B | |
| -1.89% | -2.00% | +0.92% | +29.79% | +15.69% | +1.45% | +82.46% | +2.58% | +1,012.98% | 40.73B | |
| -1.72% | -2.61% | -8.13% | +14.87% | +6.22% | +13.09% | +42.33% | -18.57% | +139.05% | 33.21B | |
| -0.17% | +3.78% | +5.75% | +31.23% | - | - | - | - | - | 17.77B | |
| -0.07% | +1.32% | +0.04% | +29.04% | +5.21% | +20.08% | +117.95% | +207.71% | +1,866.36% | 16.5B | |
| -0.56% | -0.50% | +2.01% | +9.74% | +14.10% | +11.39% | +31.41% | -43.40% | +88.81% | 14.45B | |
| -2.68% | -0.56% | +4.96% | +50.59% | +40.75% | +73.31% | +40.56% | -36.98% | +244.28% | 13.77B | |
| -3.95% | -1.90% | -3.75% | +4.01% | -13.11% | -10.95% | -36.70% | -39.06% | +107.20% | 12.72B | |
| -0.51% | +3.24% | +23.52% | +32.31% | +8.87% | -19.86% | - | - | - | 11.66B | |
| -0.17% | +0.18% | +0.03% | +37.34% | +22.96% | +33.64% | +0.68% | -43.04% | +161.71% | 11.36B | |
| +3.64% | +0.38% | -5.57% | +93.40% | +50.40% | +31.17% | +58.14% | -48.92% | - | 10.37B | |
| +0.19% | -0.27% | -2.30% | +39.18% | +19.59% | +764.98% | +1,590.55% | +15.81% | - | 9.82B | |
| +3.11% | +2.59% | -11.48% | +13.29% | -16.11% | +34.13% | +494.12% | +191.07% | +2,476.53% | 9.93B | |
| -0.78% | -2.17% | +8.32% | +57.50% | +49.69% | +169.23% | +514.94% | +85.61% | - | 9.76B | |
| -2.38% | -5.29% | +0.27% | -22.89% | -28.32% | -7.03% | +37.61% | +53.39% | +83.94% | 9.65B | |
| +0.15% | -0.38% | +0.05% | +48.87% | +67.09% | +159.73% | +666.09% | +214.73% | +1,061.02% | 9.43B | |
| -2.51% | -2.33% | +0.19% | +16.97% | -10.47% | -15.38% | -8.66% | -32.21% | +36.17% | 8.99B | |
| Average | -0.82% | -0.17% | +1.14% | +30.51% | +22.85% | +94.42% | +247.84% | +62.62% | +593.13% | 18.88B | |
| Weighted average by Cap. | -1.22% | -0.59% | +0.99% | +29.46% | +31.23% | +91.50% | +190.14% | +87.18% | +513.09% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
